EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares shot up 10.8% during mid-day trading on Saturday . The stock traded as high as GBX 26.60 ($0.33) and last traded at GBX 26.60 ($0.33). Approximately 1,224,627 shares changed hands during mid-day trading, an increase of 205% from the average session volume of 401,221 shares. The stock had previously closed at GBX 24 ($0.30).
EKF Diagnostics Stock Up 10.8 %
The business’s fifty day simple moving average is GBX 26.38 and its two-hundred day simple moving average is GBX 27.87. The company has a market cap of £120.69 million, a PE ratio of 2,660.00 and a beta of 0.57. The company has a debt-to-equity ratio of 1.78, a current ratio of 4.59 and a quick ratio of 1.77.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Read More
- Five stocks we like better than EKF Diagnostics
- How to Invest in Biotech Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- 3 Grocery Stocks That Are Proving They Are Still Essential
- CarMax Gets in Gear: Is Now the Time to Buy?
- Why Are Stock Sectors Important to Successful Investing?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
